- DocumentComprehensive safety analysis of concomitant drotrecogin alfa (activated) and prophylactic heparin use in patients with severe sepsisuploaded byMARIANO ALEJANDRO MIGNINI
- DocumentHemodynamic effects of recombinant human activated Protein Cuploaded byMARIANO ALEJANDRO MIGNINI
- DocumentThe safety profile of drotrecogin alfa (activated)uploaded byMARIANO ALEJANDRO MIGNINI
- DocumentExtended drotrecogin alfa (activated) treatment in patients with prolonged septic shockuploaded byMARIANO ALEJANDRO MIGNINI
- DocumentPeripheral arterial blood pressure monitoring adequately tracks central arterial blood pressure in critically ill patients an observational studyuploaded byMARIANO ALEJANDRO MIGNINI